Preclinical and clinical results of dual orexin receptor antagonist, suvorexant (BELSOMRA®), a novel therapeutic agent for insomnia

2Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Cite

CITATION STYLE

APA

Tanaka, Y., Aoki, I., Ishine, T., Renger, J. J., Winrow, C. J., & Hisada, S. (2016). Preclinical and clinical results of dual orexin receptor antagonist, suvorexant (BELSOMRA®), a novel therapeutic agent for insomnia. Folia Pharmacologica Japonica, 148(1), 46–56. https://doi.org/10.1254/fpj.148.46

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free